XM does not provide services to residents of the United States of America.

France's Ubisoft postpones 'Assassin's Creed Shadows' release, cuts guidance



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-France's Ubisoft postpones 'Assassin's Creed Shadows' release, cuts guidance</title></head><body>

Added details, CEO and CFO comments throughout

By Mathias de Rozario

Sept 25 (Reuters) -French videogame maker Ubisoft UBIP.PA has postponed the release of "Assassin's Creed Shadows" by three months to Feb. 14, 2025 and cut its net bookings guidance.

Ubisoft said in a statement that net bookings are now seen falling from last year, to around 1.95 billion euros for the company's 2024-2025 fiscal year. For the second quarter through end-September, net bookings are expected to be worth around 350 million to 370 million euros, compared with the 500 million euros anticipated previously.

Shares in Ubisoft touched 10-year lows this month after a muted reception to the release of its "Star Wars Outlaws" game.

They closed at 11.42 euros on Wednesday, before Ubisoft released its statement.

Ubisoft had been betting on the two titles after four years of negative cash flows with game cancellations and delays.

"Beyond the first important short-term actions undertaken, the Executive Committee, is launching a review aimed at further improving our execution," CEO Yves Guillemot said in a press release.

The family-owned company said it is now departing from the traditional video game "Season Pass" model which gives access to current and future content, but added that those who preorder "Assassin's Creed Shadows" will be granted the first expansion for free.

"As the growth transformation continues, we may progress on our cost reduction initiative, with headcounts steadily decreasing over the first half," CFO Frederick Duguet said on a call with analysts.

Ubisoft also announced that "Star Wars Outlaws" will be available on the Steam store on Nov. 21.



Reported by Mathias de Rozario; Editing by Kirsten Donovan

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.